BAWEI
837023
XI'AN WONDER
836419
Jiangsu Tiangong Technology
920068
4
Fujian Green Pine
300132
5
Yili Chuanning Biotechnology
301301
(Q3)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total operating revenue | 17.60%1.37B | 17.95%5.27B | 13.63%3.77B | 9.40%2.44B | 4.37%1.17B | -6.28%4.47B | -4.82%3.32B | -1.64%2.23B | 14.05%1.12B | 25.02%4.77B |
Operating revenue | 17.60%1.37B | 17.95%5.27B | 13.63%3.77B | 9.40%2.44B | 4.37%1.17B | -6.28%4.47B | -4.82%3.32B | -1.64%2.23B | 14.05%1.12B | 25.02%4.77B |
Other operating revenue | ---- | -65.87%95.44M | ---- | -54.86%69.92M | ---- | 26.33%279.65M | ---- | 205.97%154.88M | ---- | 3,393.01%221.37M |
Total operating cost | 19.84%1.18B | 18.33%4.6B | 13.81%3.29B | 11.33%2.13B | 3.14%985.8M | -0.85%3.89B | 2.90%2.89B | 6.52%1.91B | 15.54%955.77M | 21.70%3.92B |
Operating cost | 18.57%1.13B | 19.89%4.45B | 15.58%3.18B | 12.86%2.06B | 6.69%954.5M | -1.72%3.71B | 1.25%2.75B | 5.86%1.82B | 15.05%894.68M | 24.34%3.78B |
Operating tax surcharges | -6.60%1.46M | -52.96%6.57M | -62.98%4.42M | -67.81%3.21M | -72.03%1.56M | -32.13%13.98M | -26.80%11.94M | 9.86%9.98M | 43.51%5.57M | 53.53%20.59M |
Administration expense | 24.29%49.47M | 10.90%175.28M | 1.94%125.5M | -1.97%81.03M | 0.40%39.8M | 4.94%158.05M | 15.31%123.12M | 15.88%82.66M | 10.54%39.65M | 11.99%150.6M |
Financial expense | 77.28%-2.62M | -1,323.35%-40.37M | -5,020.13%-25.8M | -162.63%-16.86M | -172.57%-11.52M | 89.48%-2.84M | 101.60%524.38K | 26.36%-6.42M | 61.65%15.87M | -173.66%-26.96M |
-Interest expense (Financial expense) | -42.54%3.04M | -0.06%20.28M | -8.82%13.68M | -25.13%7.84M | 15.53%5.29M | -48.47%20.29M | -50.53%15M | -49.91%10.46M | -51.23%4.58M | 99.06%39.37M |
-Interest Income (Financial expense) | 21.77%-9.6M | -23.95%-45.16M | -63.97%-32.76M | -96.04%-22.36M | -282.88%-12.27M | -465.56%-36.43M | -415.38%-19.98M | -436.95%-11.4M | -266.81%-3.2M | -60.48%-6.44M |
Research and development | -14.68%1.24M | 30.00%8.66M | 79.42%4.12M | 62.26%2.55M | --1.45M | --6.66M | --2.3M | --1.57M | ---- | ---- |
Credit Impairment Loss | -193.97%-1.66M | -616.29%-4.5M | -303.65%-2.15M | -357.20%-1.71M | -811.77%-566.22K | -261.74%-627.56K | -224.25%-532.91K | -426.80%-374.12K | -83.30%79.55K | 186.54%388.01K |
Asset Impairment Loss | 62.49%48.87K | 35.82%13.2K | 27.45%37.05K | -63.02%24.75K | -5.23%30.07K | 100.11%9.72K | 145.54%29.07K | 585.71%66.93K | 155.01%31.73K | -102,564.43%-8.94M |
Other net revenue | 9.59%40.6M | -2.56%55.07M | -18.32%44.74M | -13.86%44.85M | -17.82%37.05M | 8.61%56.52M | 9.32%54.77M | 12.86%52.06M | 91.97%45.08M | -54.58%52.04M |
Invest income | -107.29%-1.22M | 1,128.25%1.83M | -257.48%-1.41M | -278.09%-1.66M | -141.03%-590.96K | -97.85%148.64K | -87.06%896K | -86.91%933.42K | -104.76%-245.19K | -81.09%6.91M |
-Including: Investment income associates | -107.29%-1.22M | 183.81%1.85M | 7.90%-1.35M | -278.09%-1.66M | -141.03%-590.96K | -131.57%-2.21M | -120.87%-1.47M | -87.09%933.42K | -104.76%-245.19K | -81.37%7.01M |
Asset deal income | 13,219.50%276.72K | -86.49%337.5K | -99.28%17.88K | -100.17%-4.13K | -99.92%2.08K | 12,660.77%2.5M | 71,615.60%2.49M | 195,892.31%2.47M | 24,843.13%2.44M | -99.17%19.57K |
Other revenue | 13.08%43.17M | 5.32%57.39M | -7.02%48.24M | -1.56%48.2M | -10.75%38.17M | 1.54%54.49M | 21.20%51.89M | 25.87%48.96M | 138.66%42.77M | -29.51%53.66M |
Operating profit | 6.16%231.77M | 13.83%723.75M | 8.91%525.01M | -3.64%361.24M | 5.20%218.32M | -29.16%635.83M | -33.68%482.06M | -28.34%374.88M | 17.43%207.52M | 27.27%897.5M |
Add:Non operating Income | -95.09%39.29K | -79.56%5.48M | -96.14%1.03M | -96.98%805.85K | 7,307.79%800.04K | 576.05%26.79M | 1,230.84%26.72M | 1,700.50%26.68M | -94.77%10.8K | 229.91%3.96M |
Less:Non operating expense | --66.33 | -40.49%20.25K | 71.65%14.73K | -86.36%1.17K | ---- | -72.71%34.02K | -91.10%8.58K | 9.87%8.58K | ---- | -99.29%124.67K |
Total profit | 5.79%231.81M | 10.05%729.2M | 3.39%526.03M | -9.84%362.05M | 5.58%219.12M | -26.49%662.58M | -30.19%508.77M | -23.46%401.56M | 17.30%207.53M | 30.83%901.34M |
Less:Income tax cost | 7.58%56.77M | 7.29%173.75M | -0.21%122.09M | -10.19%86.62M | 1.05%52.77M | -29.99%161.95M | -34.09%122.35M | -27.33%96.44M | 16.82%52.22M | 37.72%231.32M |
Net profit | 5.22%175.04M | 10.95%555.45M | 4.53%403.94M | -9.73%275.43M | 7.11%166.35M | -25.28%500.64M | -28.86%386.42M | -22.15%305.12M | 17.46%155.31M | 28.61%670.02M |
Net profit from continuing operation | 5.22%175.04M | 10.95%555.45M | 4.53%403.94M | -9.73%275.43M | 7.11%166.35M | -25.28%500.64M | -28.86%386.42M | -22.15%305.12M | 17.46%155.31M | 28.61%670.02M |
Less:Minority Profit | 89.05%-52.18K | 150.49%1.72M | 59.78%-1.02M | 34.40%-1.33M | 70.25%-476.68K | -2,726.49%-3.4M | -1,769.49%-2.54M | -2,060,834.07%-2.03M | -3,774.20%-1.6M | -66.90%129.37K |
Net profit of parent company owners | 4.95%175.09M | 9.86%553.74M | 4.11%404.96M | -9.89%276.76M | 6.32%166.83M | -24.76%504.03M | -28.38%388.96M | -21.63%307.14M | 18.71%156.91M | 28.68%669.89M |
Earning per share | ||||||||||
Basic earning per share | 0.00%0.13 | 7.69%0.42 | 3.33%0.31 | -8.70%0.21 | 8.33%0.13 | -31.58%0.39 | -34.78%0.3 | -30.30%0.23 | 9.09%0.12 | 26.67%0.57 |
Diluted earning per share | 0.00%0.13 | 7.69%0.42 | 3.33%0.31 | -8.70%0.21 | 8.33%0.13 | -31.58%0.39 | -34.78%0.3 | -30.30%0.23 | 9.09%0.12 | 26.67%0.57 |
Other composite income | ||||||||||
Total composite income | 5.22%175.04M | 10.95%555.45M | 4.53%403.94M | -9.73%275.43M | 7.11%166.35M | -25.28%500.64M | -28.86%386.42M | -22.15%305.12M | 17.46%155.31M | 28.61%670.02M |
Total composite income of parent company owners | 4.95%175.09M | 9.86%553.74M | 4.11%404.96M | -9.89%276.76M | 6.32%166.83M | -24.76%504.03M | -28.38%388.96M | -21.63%307.14M | 18.71%156.91M | 28.68%669.89M |
Total composite income of minority owners | 89.05%-52.18K | 150.49%1.72M | 59.78%-1.02M | 34.40%-1.33M | 70.25%-476.68K | -2,726.49%-3.4M | -1,769.49%-2.54M | -2,060,834.07%-2.03M | -3,774.20%-1.6M | -66.90%129.37K |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
Audit Opinions | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion |
Auditor | -- | Deloitte Huayong Certified Public Accountants (Special General Partnership) | -- | -- | -- | PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership) | -- | -- | -- | PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.